← All startups
Ventus Therapeutics
Structural bio platform to discover small molecules against hard-to-drug, highly validated innate immunity targets
Latest roundFunding roundFeb 7, 2022
Team37
NameLocationLinksContact
Christine Ha
Chief Financial Officer
New York, New York, United States
—
Daniel Koerwer
Chief Operating Officer
Boston, Massachusetts, United States
—
Marcelo Bigal
President
—
—
Michael Crackower
Chief Scientific Officer
United States
—
Mona Kotecha
Chief Medical Officer
Greater Boston
—
Andre Matta
Vice President Clinical Research
United States
—
David Schubert
SVP Regulatory And Quality
—
—
Loraine Warner
Vp
—
—
Paul Armour
SVP Finance
—
—
Raminder Gill
Vp
—
—
Robin A. Weatherhead
Vice President
Greater Boston
—
Stephane Ciblat
VP
—
—
Amy Archer
Executive Medical Director
—
—
Carole Gleeson
Sr Director
—
—
Christopher Jenkins
Associate Director
—
—
Dan McKay
Executive Director
—
—
Dolca Thomas
Director
—
—
Heather Dowty
Senior Director
—
—
John Cassidy
Director
—
—
Michelle Joseph
Senior Director Clinical Data Management
—
—
Nandita Shangari
Director
—
—
Pauline Sullivan
Senior Director of Quality
—
—
Ramsay Beveridge
Associate Director
—
—
Sarah Williams
Director
—
—
Steven P. James
Director
—
—
Francis Lefebvre
Senior Manager
—
—
Hannah Whipple-Macedo
Senior Program Manager Consultant
—
—
Heather Lokys
Executive Operations
—
—
Jenna Calvino
Senior Scientist
—
—
Jenna Epple
Associate Manager
—
—
Jeremy Rocco
Accounting Manager
—
—
Mary Njenga
Senior Clinical Project Manager
—
—
Michèle Pokluda
Executive Operations
—
—
Mohamed Diallo
In Vitro DMPK Manager
—
—
Hao Wu
Chairman of Scientific Advisory Board
—
—
Jane Pritchett Henderson
New York, New York, United States
—
Markus Warmuth
Member Board Of Directors
Cambridge, Massachusetts, United States
—